Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Johnson and Johnson
Boehringer Ingelheim
Baxter
Merck

Last Updated: January 26, 2020

DrugPatentWatch Database Preview

US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2005120585

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: WO2005120585

These international patent data are derived from patent families, based on US drug-patent linkages. Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.
US Patent Number Estimated Patent Expiration Generic Name US Applicant US Tradename
  Start Trial 2024-06-06 asparaginase Merck ELSPAR
  Start Trial 2024-06-06 filgrastim Amgen NEUPOGEN
  Start Trial 2024-06-06 rituximab Genentech RITUXAN
  Start Trial 2024-06-06 trastuzumab Genentech HERCEPTIN
  Start Trial 2024-06-06 rituximab; hyaluronidase (human recombinant) Genentech Inc RITUXAN HYCELA
  Start Trial 2024-06-06 trastuzumab; hyaluronidase-oysk Genentech Inc HERCEPTIN HYLECTA
>US Patent Number >Estimated Patent Expiration >Generic Name >US Applicant >US Tradename

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
McKesson
McKinsey
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.